Abbott strengthens its connected care technologies with latest neurosphere™ mypath™ digital health app

Now available for use with both apple and android devices, the app helps people track pain relief during the treatment journey with neurostimulation devices updated app provides doctors with an at-a-glance assessment of their patients while on their treatment journey abbott park, ill., april 25, 2022 /prnewswire/ -- abbott (nyse: abt) today announced that it has launched an upgraded version of its neurosphere™ mypath™ digital health app with enhanced functionality that will help doctors more closely track their patients as they trial abbott neurostimulation devices to address their chronic pain.
ABT Ratings Summary
ABT Quant Ranking